Aspire Bolsters Dermatology With Canute Acquisition

Product Portfolio Will Enhance Existing Offering Of UK Value-Added Medicines Player

 
• By Dave Wallace

Aspire Pharma has bolstered its dermatology portfolio by striking a deal to acquire “all assets” of another UK-based player, Canute Pharma.

Handshake with UK flag in background
Aspire has struck a deal for Canute’s assets • Source: Shutterstock

More from Deals

More from Business